Introduction
During our work on cardiaoctive steroids we studied the elimination of the 12/3-sulfoxy-group. It is well known that 12/J-tosyloxy-or 12/3-mesyloxysteroids with C/D-trans juncture undergo elimination to yield C-nor-D-homo steroids with 12(13) or 13(18) double bonds [1] [2] [3] [4] [5] [6] . The same rearrangement product was obtained by the reaction of a 12/3-tosyloxycardenolide [7] with C/D-eis juncture. No GrobFragmentation to 14-keto-12-en-13(14)-secosteroids was observed [7] [8] [9] [10] . We now wish to report that the C-nor-D-homo-structure [7] proposed earlier for the rearrangement product must be corrected.
Results and Discussion
Elimination of the 12/3-hydroxy-group in digoxigenin (1) can be achieved under basic conditions if the 12/3-alcohol is converted to a sulfonic ester.
Originally it was proposed [7] that the elimination of the 12/3-tosyloxy-cardenolide (4) resulted in a C-nor-D-homo steroid (6) .
The sulfoxy compounds could be synthesized in the following way. Digoxigenin (1) was oxidized to * Reprint request to Prof. Dr. G. G. Habermehl. Verlag der Zeitschrift für Naturforschung, D-7400 Tübingen 0340-5087/85/0500-0656/$ 01.00/0 digoxigenone (2) by either Pt/0 2 [11] or N-bromosuccinimide in acetone. The advantage of the latter reaction is the high selectivity for the 3/3-hydroxy group and a short reaction time. Also, with an excess of the bromo-compound no reaction at the 12/3-position took place, because bromination of acetone was preferred. Sulfonation of 2 with methanesulfonylchloride to 3 or toluene-4-sulfonylchloride to 4 [7] yielded the corresponding sulfonicesters. The mesylation to 3 in 30 min is much faster than the tosylation of 4 which takes 24 h. The sulfonic esters 3 and 4 were eliminated in pyridine or collidine yielding a rearranged product. (Table I) . Application of two dimensional Fourier-transform NMR-techniques [12] lead to the structure 5.
The 2D-proton-proton shift correlation spectrum ( The rearrangement may be explained by the migration of C(17) to 5 whereas migration of C(14) could result in formation of 6. Elimination of a proton from C(18) forms the exocyclic double bond.
To prove the general validity, the same rearrangement was also studied with a 20-keto side chain, instead of the butenolide system. Starting with 3/3,12/3-diacetoxy-14/3-hydroxyandrostane-17/3-carboxylic-acid (7) the 20-keto-pregnane (8) was obtained through methylation with methyl-lithium.
Selective oxidation with Nbromosuccinimide as described before yielded the pregnane-3,20-dione (9). Reaction with methanesulfonylchloride in pyridine to 10 and elimination in collidine under reflux resulted in 11.
9 R = H 10 R = CHjSOJ-J H and 13 C NMR experiments indicated a rearrangement because of the presence of olefinic protons and only one methyl-signal. Structure 1 could be proven with 2D-proton-proton-shift-correlation (Fig. 2) The 2D-J H 13 C shift correlation experiment allowed the determination of the chemical shift at H(16), H(12), H(ll), H(9) and H(8) in the unresolved area of the ID-proton spectrum (Fig. 3) . The data confirmed the correlation from the cosyexperiment.
Intraperitoneal application of 5 in doses up to 50 mg/kg showed no toxicity in mice.
Further work to explain this rearrangement is presently under investigation.
Experimental
Melting points are uncorrected: Kofler hot stage apparatus. *H NMR and 13 C NMR spectra were taken on a Bruker AM-300 or AM-400. 2D-NMR experiments were carried out with a Varian XL-400 and a Jeol GX-270. IR-spectra were recorded on a Perkin Elmer 197 spectrometer. All the synthesized substances were analyzed for C,H and the results were within ±0.3% of theoretical values.
14ß-Hydroxy-3-oxo-13,17-seco-12,17-cyclo-card-13(18),20(22)-dienolide (5)
A solution of 3 (500 mg; 1.05 moles) in 6 ml pyridine was refluxed for 1 h. The solvent was evaporated in vacuo and the residue was dissolved in chloroform. After washing two times with 0.1 N HCl and drying over Na 2 S0 4 
3ß, 12ß,14ß-Trihydroxy-5ß-pregnane-20-one (8)
Methyl-lithium (41 ml; 65.6 mmoles of a 1.6 M ether solution) was added to 3/?,14/3-diacetoxy-14/3-hydroxy-5/3-androstane-carboxylic acid (7) (3.7 g; 8.5 mmoles) dissolved in 100 ml dry THF at 0 °C and stirred for 1 h. After hydrolysation with water and evaporation of THF under vacuum the residue was extracted three times with 50 ml chloroform. The organic extracts were washed with NaHC0 3 solution and dried over Na 2 S0 4 . Evaporation in vacuo yielded a syrup which could be crystallized with acetone/water (1.34 g; 45%) 
12ß, 14ß-Dihydroxy-3-oxo-card-20(22)-enolide
Digoxigenin (1) (2.3 g; 5.13 mmoles) was dissolved in 160 ml acetone, 20 ml water and 3 ml acetic acid. After adding N-bromosuccinimide (1.5 g; 8.4 mmoles) it was stirred for 1 h. Intermediately an orange colour appeared. The mixture was neutralized with NaHC0 3 , Evaporation in vacuo and extraction of the water phase four times with 150 ml chloroform resulted, after evaporation, in a white foam. Crystals were obtained from acetone/water (1. 
ß-Hydroxy-3-oxo-12 ß-methanesulfoxy-card-20(22)-enolide (3)
The 3-keto-compound 2 (500 mg; 1.29 mmoles) was dissolved in 20 ml pyridine and 0.33 ml methane-sulfonyl-chloride. After stirring for 30 min at room temperature the mixture was poured into water, acidified with HCl and extracted three times with 50 ml chloroform. Evaporation after drying over Na 2 S0 4 yielded a white foam. The residue was crystallized with etyl-acetate/cyclohexane. (520 mg; 90%); m.p. 121 °C. 'H NMR (300 MHz) (CDC1 3 ):
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